NCT07065136View on ClinicalTrials.gov

Evaluation of 627 in Healthy Adult Subjects

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

108

Participants

Timeline

Start Date

July 20, 2025

Primary Completion Date

September 18, 2026

Study Completion Date

September 18, 2026

Conditions

Healthy Subjects (HS)

Interventions

BIOLOGICAL

627

subcutaneous injection

OTHER

Placebo

Single subcutaneous injection

All Listed Sponsors

lead

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

INDUSTRY